The impact of physiological state and environmental stress on bacterial load estimation methodologies for Mycobacterium tuberculosis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 10 2024
Historique:
received: 11 06 2024
accepted: 25 09 2024
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 31 10 2024
Statut: epublish

Résumé

When processed in solid or liquid medium, tuberculosis patient samples yield different proportions of a heterogenous bacterial community over the duration of treatment. We aimed to derive a relationship between methodologies for bacterial load determination and assess the effect of the growth phase of the parent culture and its exposure to stress on the results. Mycobacterium tuberculosis H37Rv was grown with and without antibiotic (isoniazid or rifampicin) and sampled on day 0, 3, 11 and 21 of growth in broth culture. The bacterial load was estimated by colony counts and the BD BACTEC MGIT system. Linear and nonlinear mixed-effects models were used to describe the relationship between time-to-positivity (TTP) and time-to-growth (TTG) versus colony forming units (CFU), and growth units (GU) versus incubation time in MGIT. For samples with the same CFU, antibiotic-treated and stationary phase cells had a shorter TTP than antibiotic-free controls and early-logarithmic phase cells, respectively. Similarly, stationary phase samples reached higher GUs and had shorter TTG than early-log phase ones. This suggests that there is a population of bacterial cells that can be differentially recovered in liquid medium, giving us insight into the physiological states of the original culture, aiding the interpretation of clinical trial outputs.

Identifiants

pubmed: 39477982
doi: 10.1038/s41598-024-74318-3
pii: 10.1038/s41598-024-74318-3
doi:

Substances chimiques

Rifampin VJT6J7R4TR
Isoniazid V83O1VOZ8L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26108

Subventions

Organisme : Wellcome Trust
ID : 220587/Z/20/Z
Pays : United Kingdom

Informations de copyright

© 2024. The Author(s).

Références

WHO. Global tuberculosis report 2023. (2023).
Jindani, A., Aber, V. R., Edwards, E. A. & Mitchison, D. A. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 121, 939–949 (1980).
pubmed: 6774638
Mitchison, D. A. & Strum, A. W. The measurement of early bactericidal activity. Baillières Clin. Infect. Dis. 4, 185–206 (1997).
Diacon, A. H. et al. Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. Eur. J. Clin. Microbiol. Infect. Dis. 29, 1561–1565 (2010).
doi: 10.1007/s10096-010-1043-7 pubmed: 20820832
Diacon, A. H. et al. Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents. Clin. Microbiol. Infect. 18, 711–717 (2012).
doi: 10.1111/j.1469-0691.2011.03626.x pubmed: 21851489
Bark, C. M. et al. Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures. Tuberculosis 91, 257–259 (2011).
doi: 10.1016/j.tube.2011.01.004 pubmed: 21353641
Phillips, P. P. J. et al. A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens. BMC Med. 15, 1–9 (2017).
doi: 10.1186/s12916-017-0955-9
Saito, K. et al. Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations. Proc. Natl. Acad. Sci. 114, E4832–E4840 (2017).
doi: 10.1073/pnas.1705385114 pubmed: 28559332
Dhillon, J., Fourie, P. B. & Mitchison, D. A. Persister populations of Mycobacterium tuberculosis in sputum that grow in liquid but not on solid culture media. J. Antimicrob. Chemother. 69, 437–440 (2014).
doi: 10.1093/jac/dkt357 pubmed: 24072170
Mukamolova, G. V., Turapov, O., Malkin, J., Woltmann, G. & Barer, M. R. Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum. Am. J. Respir. Crit. Care Med. 181, 174–180 (2010).
doi: 10.1164/rccm.200905-0661OC pubmed: 19875686
Bowness, R. et al. The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations. J. Antimicrob. Chemother. 70, 448–455 (2015).
doi: 10.1093/jac/dku415 pubmed: 25344806
Caceres, N. et al. Evolution and role of corded cell aggregation in Mycobacterium tuberculosis cultures. Tuberculosis 93, 690–698 (2013).
doi: 10.1016/j.tube.2013.08.003 pubmed: 24011631
Barr, D. A. et al. Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria. Sci. Rep. 11, 18661 (2021).
doi: 10.1038/s41598-021-98176-5 pubmed: 34545154
Kieser, K. J. & Rubin, E. J. How sisters grow apart: Mycobacterial growth and division. Nat. Rev. Microbiol. 12, 550–562 (2014).
doi: 10.1038/nrmicro3299 pubmed: 24998739 pmcid: 6556109
Aldridge, B. B. et al. Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335, 100–104 (2012).
doi: 10.1126/science.1216166 pubmed: 22174129
Joyce, G. et al. Cell division site placement and asymmetric growth in mycobacteria. (2012).
Singh, B. et al. Asymmetric growth and division in M ycobacterium spp.: Compensatory mechanisms for non-medial septa. Mol. Microbiol. 88, 64–76 (2013).
doi: 10.1111/mmi.12169 pubmed: 23387305
Santi, I., Dhar, N., Bousbaine, D., Wakamoto, Y. & McKinney, J. D. Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria. Nat. Commun. 4, 2470 (2013).
doi: 10.1038/ncomms3470 pubmed: 24036848
Avery, S. V. Microbial cell individuality and the underlying sources of heterogeneity. Nat. Rev. Microbiol. 4, 577–587 (2006).
doi: 10.1038/nrmicro1460 pubmed: 16845428
Dhar, N., McKinney, J. & Manina, G. Phenotypic heterogeneity in Mycobacterium tuberculosis. Tuberc. Tuber. Bacillus 671–697 (2017).
Boeckmann, A. J., Sheiner, L. B. & Beal, S. L. NONMEM User’s Guide, Part V. Introductory Guide. p 48. (2011).
Keizer, R. J., Karlsson, M. O. & Hooker, A. Modeling and simulation workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose. CPT Pharmacomet. Syst. Pharmacol. 2, 1–9 (2013).
doi: 10.1038/psp.2013.24
Lindbom, L., Ribbing, J. & Jonsson, E. N. Perl-speaks-NONMEM (PsN)—A Perl module for NONMEM related programming. Comput. Methods Programs Biomed. 75, 85–94 (2004).
doi: 10.1016/j.cmpb.2003.11.003 pubmed: 15212851
Chambers, J. M. Software for data analysis: Programming with R. vol. 2 (Springer, 2008).

Auteurs

Arundhati Maitra (A)

Institute for Global Health, University College London, London, UK.
Centre for Clinical Microbiology, University College London, London, UK.

Marie Wijk (M)

Institute for Global Health, University College London, London, UK. sjlmar001@myuct.ac.za.
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. sjlmar001@myuct.ac.za.

Hasmik Margaryan (H)

Centre for Clinical Microbiology, University College London, London, UK.

Paolo Denti (P)

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Timothy D McHugh (TD)

Centre for Clinical Microbiology, University College London, London, UK.

Frank Kloprogge (F)

Institute for Global Health, University College London, London, UK. f.kloprogge@ucl.ac.uk.
Centre for Clinical Microbiology, University College London, London, UK. f.kloprogge@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH